Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation

J Novy, E Bartolini, GS Bell, JS Duncan, JW Sander - Epilepsy research, 2013 - Elsevier
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …
被引用次数：54 相关文章

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation

J Novy, E Bartolini, GS Bell, JS Duncan… - Epilepsy …, 2013 - pubmed.ncbi.nlm.nih.gov
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation.

J Novy, E Bartolini, GS Bell, JS Duncan… - Epilepsy …, 2013 - europepmc.org
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation

J Novy, E Bartolini, GS Bell, JS Duncan, JW Sander - Epilepsy Research, 2013 - infona.pl
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …

[引用][C] Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation

J NOVY, E BARTOLINI, GS BELL… - Epilepsy …, 2013 - pascal-francis.inist.fr
Long-term retention of lacosamide in a large cohort of people with medically refractory
epilepsy: A single centre evaluation CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation

J Novy, E Bartolini, GS Bell, JS Duncan, JW Sander - Epilepsy Research, 2013 - infona.pl
Lacosamide (LCM) is a recently licensed antiepileptic drug available in the UK since 2008. It
is thought to act through modulation of sodium channel slow inactivation. Its efficacy and …